Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Odero

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Cancer Genetics and Cytogenetics|April 1, 1995
A variant t(14;17) in acute promyelocytic leukemia. Positive response to retinoic acid treatmentJ C Cigudosa, M J Calasanz, M D Odero, et al.
Genes, Chromosomes & Cancer|April 25, 2001
Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotypingM D Odero, K Carlson, M J Calasanz, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
A recurrent translocation, t(3;11)(q21;q13), found in two distinct cases of acute myeloid leukemiaJ C Cigudosa, M J Calasanz, M D Odero, et al.
Leukemia|January 15, 2011
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effectI Cristóbal, L Garcia-Orti, C Cirauqui, et al.
Cancer Letters|January 29, 2013
Edelfosine lipid nanosystems overcome drug resistance in leukemic cell linesBeatriz Lasa-Saracíbar, Ander Estella-Hermoso de Mendoza, Faustino Mollinedo, et al.
Oncotarget|September 15, 2017
MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemiaRaffaella Pippa, Ana Dominguez, Raquel Malumbres, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
A novel t(2;3)(p11;q27) in a case of follicular lymphomaCinzia Tapinassi, Carla Micucci, Idoya Lahortiga, et al.
Blood|February 28, 2002
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)Jan Cools, Nicole Mentens, Maria D Odero, et al.
Histopathology|June 6, 2002
Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomasI Zudaire, M D Odero, C Caballero, et al.
Anales Del Sistema Sanitario De Navarra|July 24, 2003
[New cytogenetic prognostic markers in breast cancer]M I Zudaire, M D Odero, M C Caballero, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Cancer Genetics and Cytogenetics|April 1, 1995
A variant t(14;17) in acute promyelocytic leukemia. Positive response to retinoic acid treatmentJ C Cigudosa, M J Calasanz, M D Odero, et al.
Genes, Chromosomes & Cancer|April 25, 2001
Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotypingM D Odero, K Carlson, M J Calasanz, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
A recurrent translocation, t(3;11)(q21;q13), found in two distinct cases of acute myeloid leukemiaJ C Cigudosa, M J Calasanz, M D Odero, et al.
Leukemia|January 15, 2011
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effectI Cristóbal, L Garcia-Orti, C Cirauqui, et al.
Cancer Letters|January 29, 2013
Edelfosine lipid nanosystems overcome drug resistance in leukemic cell linesBeatriz Lasa-Saracíbar, Ander Estella-Hermoso de Mendoza, Faustino Mollinedo, et al.
Oncotarget|September 15, 2017
MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemiaRaffaella Pippa, Ana Dominguez, Raquel Malumbres, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
A novel t(2;3)(p11;q27) in a case of follicular lymphomaCinzia Tapinassi, Carla Micucci, Idoya Lahortiga, et al.
Blood|February 28, 2002
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)Jan Cools, Nicole Mentens, Maria D Odero, et al.
Histopathology|June 6, 2002
Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomasI Zudaire, M D Odero, C Caballero, et al.
Anales Del Sistema Sanitario De Navarra|July 24, 2003
[New cytogenetic prognostic markers in breast cancer]M I Zudaire, M D Odero, M C Caballero, et al.
Pageof 8